VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_16-vv-00339
Package ID: USCOURTS-cofc-1_16-vv-00339
Petitioner: Jonathan Catrow
Filed: 2016-12-09
Decided: 2017-04-11
Vaccine: influenza
Vaccination date: 2015-02-17
Condition: Guillain-Barré syndrome
Outcome: compensated
Award amount USD: 86610

AI-assisted case summary:
Jonathan Catrow filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered Guillain-Barré syndrome (GBS) as a result of receiving an influenza and/or Tdap vaccine on or about February 17, 2015. He further alleged that he suffered residual effects from this injury for more than six months. The respondent denied that the vaccines caused his alleged GBS or any other injury, and denied that his current disabilities were sequelae of a vaccine-related injury. Despite the respondent's denial, the parties filed a joint stipulation on December 9, 2016, agreeing that compensation should be awarded. The Chief Special Master found the stipulation reasonable and adopted it as the Court's decision. Jonathan Catrow was awarded a lump sum of $86,610.23, representing compensation for all items of damages available under the Vaccine Act. The decision directed the clerk of the court to enter judgment in accordance with this decision.

Theory of causation field:
unclear

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_16-vv-00339-0
Date issued/filed: 2017-04-11
Pages: 7
Docket text: PUBLIC DECISION (Originally filed: 12/09/2016) regarding 25 DECISION Stipulation/Proffer ( Signed by Chief Special Master Nora Beth Dorsey.)(mpj) Copy to parties.
--------------------------------------------------------------------------------
Case 1:16-vv-00339-UNJ Document 33 Filed 04/11/17 Page 1 of 7
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 16-0339V
Filed: December 9, 2016
UNPUBLISHED
* * * * * * * * * * * * * * * * * * * * * * * * * * * *
JONATHAN CATROW, *
*
Petitioner, * Joint Stipulation on Damages;
v. * Influenza (“Flu”) and Tetanus Diphtheria
* Acellular Pertussis (“Tdap”) Vaccines;
SECRETARY OF HEALTH * Guillain-Barré Syndrome (“GBS”);
AND HUMAN SERVICES, * Special Processing Unit (“SPU”)
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * * * *
Amber Diane Wilson, Maglio Christopher & Toale, PA, Washington, DC, for petitioner.
Mallori Browne Openchowski, U.S. Department of Justice, Washington, DC, for
respondent.
DECISION ON JOINT STIPULATION1
Dorsey, Chief Special Master:
On March 16, 2016, Jonathan Catrow (“petitioner”) filed a petition for
compensation under the National Vaccine Injury Compensation Program, 42 U.S.C.
§300aa-10, et seq.,2 (the “Vaccine Act”). Petitioner alleges that he suffered Guillain-
Barré syndrome (“GBS”) as a result of an influenza (“flu”) and/or Tetanus diphtheria
acellular pertussis (“Tdap”) vaccines he received on or about February 17, 2015.
Petition at 1-2; Stipulation, filed December 9, 2016, at ¶ 2, 5. Petitioner further alleges
that he suffered the residual effects of this injury for more than six months. Petition at 2;
Stipulation at ¶ 4. “Respondent denies that the flu and/or Tdap vaccines caused
petitioner’s alleged GBS or any other injury and further denies that his current
disabilities are sequela of a vaccine-related injury.” Stipulation at ¶ 6.
1 Because this unpublished decision contains a reasoned explanation for the action in this case, the
undersigned intends to post it on the United States Court of Federal Claims' website, in accordance with
the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). In accordance with Vaccine Rule 18(b), petitioner has 14 days to
identify and move to redact medical or other information, the disclosure of which would constitute an
unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits
within this definition, the undersigned will redact such material from public access.
2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).

Case 1:16-vv-00339-UNJ Document 33 Filed 04/11/17 Page 2 of 7
Nevertheless, on December 9, 2016, the parties filed the attached joint
stipulation, stating that a decision should be entered awarding compensation. The
undersigned finds the stipulation reasonable and adopts it as the decision of the Court
in awarding damages, on the terms set forth therein.
The parties stipulate that petitioner shall receive the following compensation:
A lump sum of $86,610.23, in the form of a check payable to petitioner.
Stipulation at ¶ 8. This amount represents compensation for all items of
damages that would be available under 42 U.S.C. § 300aa-15(a). Id.
The undersigned approves the requested amount for petitioner’s compensation.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of
the court is directed to enter judgment in accordance with this decision.3
IT IS SO ORDERED.
s/Nora Beth Dorsey
Nora Beth Dorsey
Chief Special Master
3 Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.
2

Case 1:16-vv-00339-UNJ Document 33 Filed 04/11/17 Page 3 of 7

Case 1:16-vv-00339-UNJ Document 33 Filed 04/11/17 Page 4 of 7

Case 1:16-vv-00339-UNJ Document 33 Filed 04/11/17 Page 5 of 7

Case 1:16-vv-00339-UNJ Document 33 Filed 04/11/17 Page 6 of 7

Case 1:16-vv-00339-UNJ Document 33 Filed 04/11/17 Page 7 of 7